Faster tracking of treatment responses
Biological sensors developed by MIT spinout Glympse Bio could help clinicians make decisions for individual patients.
Biological sensors developed by MIT spinout Glympse Bio could help clinicians make decisions for individual patients.
Specialized nanoparticles create a “breath signal” that could be used to diagnose pneumonia and other infectious or genetic diseases.
Company working with Sikes Lab to test feasibility of low-cost diagnostic that could be manufactured by the millions each day.
Hadley Sikes designs simple-to-use diagnostic devices that could benefit patients around the world.
Diagnostic platform CARMEN combines microfluidics with CRISPR-based detection technology SHERLOCK, and could one day be used for public health efforts.
Chemical engineer aims to create a test that can work in 10 minutes and doesn’t require specialized instruments or laboratory infrastructure.
MIT scientists Omar Abudayyeh and Jonathan Gootenberg explain the current state of Covid-19 testing, and how a CRISPR tool may help solve the supply problem.
Study shows that a simple urine test can reveal the presence of lung cancer in mice.
James Collins, Pablo Jarillo-Herrero, and Richard Milner have won top prizes for their work.
Smart materials change properties in response to specific DNA sequences; could be used in a variety of devices.
Noninvasive device could benefit patients with kidney disease, congestive heart failure, or dehydration.
MIT spinoff is changing the way mosquito-borne illnesses are diagnosed and aims to influence how public health officials react to disease outbreaks.
Ultra-low-power sensors carrying genetically engineered bacteria can detect gastric bleeding.
Modular blocks could enable labs around the world to cheaply and easily build their own diagnostics.
Study at MIT Medical finds most parents are capable of performing the test.